SY-1365
98%
Reagent
Code: #109706
CAS Number
1816989-16-8
blur_circular Chemical Specifications
scatter_plot
Molecular Information
Weight
586.2572 g/mol
Formula
C₃₁H₃₅ClN₈O₂
inventory_2
Storage & Handling
Storage
-20°C, airtight, dry
description Product Description
SY-1365 is primarily investigated for its potential in cancer therapy, particularly targeting CDK7, a cyclin-dependent kinase involved in cell cycle regulation and transcription. Its application focuses on disrupting the growth of cancer cells by inhibiting CDK7, which plays a critical role in controlling cell division and gene expression. This makes it a promising candidate for treating various cancers, including ovarian, breast, and hematologic malignancies. Research is ongoing to evaluate its efficacy and safety in clinical trials, with the aim of developing it as a targeted therapy for patients with limited treatment options.
format_list_bulleted Product Specification
| Test Parameter | Specification |
|---|---|
| Appearance | Crystal |
| Purity (%) | 97.5-100% |
| Infrared Spectrum | Conforms to Structure |
| NMR | Conforms To Structure |
shopping_cart Available Sizes & Pricing
Cart
No products
Subtotal:
0.00
Total
0.00
THB